Advancing Hyperlipidemia Management: Nonstatin Therapies in Guideline-Based Care
This Formulary Watch® Executive Brief is sponsored by Esperion.
This Executive Brief discusses the use of nonstatin therapies in patients with primary hyperlipidemia at high cardiovascular risk.
